On Friday NASDAQ: EDSA rose only 0.35% to $2.87 making its volume decrease to 28,515 shares as compared to the average volume of 64,425 shares. As biotech stocks usually soar during COVID-19 vaccine making so EDSA joins the race to finish the pandemic soon. The successful corporations will surely get their revenues blasting off so they can become self-sustainable for creating future vaccines. One may say with confidence, “2020 is a year of biotech industry”.
Pre-Market activity at 8:52 AM EDT shows that EDSA is nearly reaching $9.50 and digging a deep trench to stay there for long. So, it’s not too late to join this bandwagon while COVID-19 is out there causing the major economic lockdown.
CEO and Editor in Chief.
Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life